CIMINO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 10.090
EU - Europa 5.928
AS - Asia 2.947
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 50
OC - Oceania 13
Totale 19.335
Nazione #
US - Stati Uniti d'America 9.984
NL - Olanda 1.919
CN - Cina 1.616
GB - Regno Unito 1.307
UA - Ucraina 745
SG - Singapore 739
SE - Svezia 490
FI - Finlandia 319
DE - Germania 313
RU - Federazione Russa 291
TR - Turchia 244
IT - Italia 209
BR - Brasile 169
FR - Francia 120
IE - Irlanda 106
VN - Vietnam 91
CA - Canada 55
IN - India 48
BD - Bangladesh 42
BE - Belgio 34
HK - Hong Kong 33
JP - Giappone 29
KR - Corea 25
MX - Messico 25
ES - Italia 19
EU - Europa 15
AR - Argentina 14
TG - Togo 14
PL - Polonia 13
KE - Kenya 12
AU - Australia 11
RO - Romania 11
ZA - Sudafrica 11
EC - Ecuador 10
IQ - Iraq 9
IR - Iran 8
SA - Arabia Saudita 8
JM - Giamaica 7
VE - Venezuela 7
CO - Colombia 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
LT - Lituania 5
PH - Filippine 5
BO - Bolivia 4
CL - Cile 4
PE - Perù 4
PK - Pakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
LU - Lussemburgo 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
SI - Slovenia 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AT - Austria 2
BZ - Belize 2
CG - Congo 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
IM - Isola di Man 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
Totale 19.260
Città #
Amsterdam 1.912
Dallas 1.192
Southend 1.113
Woodbridge 1.095
Fairfield 951
Ashburn 799
Houston 704
Jacksonville 610
Ann Arbor 609
San Jose 455
Chandler 413
Seattle 390
Cambridge 379
Singapore 377
Nanjing 337
Wilmington 334
Beijing 237
Izmir 186
Boardman 147
Helsinki 126
Council Bluffs 119
Nanchang 111
Dublin 106
New York 96
San Mateo 90
Princeton 87
Lauterbourg 80
Bremen 77
Shenyang 77
Hebei 73
Los Angeles 71
Santa Clara 66
Tianjin 66
Changsha 56
Mülheim 52
Jiaxing 45
Moscow 44
Buffalo 43
San Diego 41
Kunming 38
Brussels 34
Jinan 34
Shanghai 34
Munich 33
Ho Chi Minh City 32
Düsseldorf 28
San Francisco 28
Istanbul 27
Hanoi 25
Velikiy Novgorod 25
Des Moines 24
Hangzhou 24
Seongnam 24
The Dalles 24
Hong Kong 22
São Paulo 22
Toronto 22
Dearborn 20
Guangzhou 20
Turku 20
Orem 18
Chicago 17
London 17
Orange 16
Denver 15
Lanzhou 15
Milan 15
Atlanta 14
Kocaeli 14
Lomé 14
Montreal 14
Chennai 13
Taizhou 13
Ningbo 12
Shenzhen 12
Brooklyn 11
Changchun 11
Frankfurt am Main 11
Tokyo 11
Warsaw 11
Venice 10
Wuppertal 10
Haikou 9
Querétaro 9
Manchester 8
Mumbai 8
Nairobi 8
West Jordan 8
Zhengzhou 8
Auburn Hills 7
Mexico City 7
Phoenix 7
Rio de Janeiro 7
Ankara 6
Boston 6
Florence 6
Fuzhou 6
Johannesburg 6
Norwalk 6
Nuremberg 6
Totale 14.748
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.209
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 442
Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat 327
Microencephalic rats as a model for cognitive disorders. 291
New therapeutic strategies in perinatal stroke 272
CHRONIC CAFFEINE TREATMENT AND ADENOSINE RECEPTORS 266
AUTORADIOGRAPHIC LOCALIZATION OF [3H]THIOCOLCHICOSIDE BINDING SITES IN THE RAT BRAIN AND SPINAL CORD 263
Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. 256
MICROENCEPHALIC RATS AS A MODEL FOR COGNITIVE DISORDERS 255
Biochemical effects of minaprine on striatal dopaminergic neurons in rats. 253
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 250
Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat 248
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. 241
Characteristics of the binding of phenoxybenzamine to calmodulin. 238
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 234
2-(SUBSTITUTED)AMINO-2,8-DIAZASPIRO[4,5]DECAN-1,3-DIONES AS POTENTIAL MUSCARINIC AGONISTS: SYNTHESIS, MODELING AND BINDING STUDIES 227
Anatomical localization of calmodulin mRNA in the rat brain with cloned cDNA and synthetic oligonucleotide probes. 226
Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke 222
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage 218
In vivo modulation of striatal phosphoproteins by dopaminergic agents. 213
In situ hybridization histochemistry as a tool to study gene expression and its regulation in the central nervous system. 212
The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. 211
Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. 209
SIMVASTATIN PROTECTS AGAINST THE LONG-LASTING BEHAVIORAL AND MORPHOLOGICAL CONSEQUENCES OF A NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY 204
Protein phosphorylation in rat pineal gland and its regulation in supersensitive and subsensitive states. 203
The hard way to acute stroke treatment. 203
Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation? 199
Study on some compensatory responses of dopaminergic system in aging rats. 197
Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: Effect of neuroprotective agents 197
3-Demetoxy-3-glycosylaminothiocolchicines: synthesis of a new class of putative muscle relaxant compounds. 197
Differential ontogenetic expression and regulation of proenkephalin and preprosomatostatin mRNAs in rat caudate-putamen as studied by in situ hybridization histochemistry. 196
Cellular expression of somatostatin in MAM-induced Microencephaly in the rat 196
Interaction of nerve growth factor with tubulin. Studies on binding and induced polymerization. 194
SELECTIVE ALTERATION IN B-50 (GAP-43) PHOSPHORYLATION IN BRAIN AREAS OF ANIMALS CHARACTERIZED BY COGNITIVE IMPAIRMENT 192
Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor 192
Neuroprotective Effect of Simvastatin in Stroke: A Comparison Between Adult and Neonatal Rat Models of Cerebral Ischemia 192
Pharmacological regulation of calmodulin. 190
Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction. 189
Differential translocation of protein kinase C isozymes in rats characterized by a chronic lack of LTP induction and cognitive impairment 189
Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat. 188
Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, α-bungarotoxin and nicotine binding sites 188
Ontogenetic development of calmodulin mRNA in rat brain using in situ hybridization histochemistry. 187
Differential effect of ganglioside GM1 on rat brain phosphoproteins: potentiation and inhibition of protein phosphorylation regulated by calcium/calmodulin and calcium/phospholipid-dependent protein kinases. 187
Expression of hexokinase mRNA in human hippocampus 185
GPR17 expressing NG2-Glia: Oligodendrocyte progenitors serving as a reserve pool after injury 184
Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex 183
Studies on binding of GTP to the microtubule protein. 182
Quantitative autoradiography of central neurotransmitter receptors: methodological and statistical aspects with special reference to computer-assisted image analysis. 181
Dopaminergic effects of buspirone, a novel anxiolytic agent. 180
Statins: multiple mechanisms of action in the ischemic brain 178
Methylazoxymethanol-induced microencephaly: persistent increase of cortical somatostatin-like immunoreactivity. 177
Acute and chronic effects of psychoactive drugs on adrenergic receptors and calmodulin. 176
[3H]-CGP 39653 mapping of glutamatergic N-methyl-D-aspartate receptors in the brain of aged rats. Neurosci. Res. Commun. 12, 31-40, 1993. 171
Changes in Protein Kinase C and its presynaptic substrate B-50/GAP-43 after intrauterine exposure to methylazoxymethanol, a treatment inducing cortical and hippocampal damage and cognitive impairments 169
Novel 3-O-glycosyl-3-demethylthiocolchicines as ligands for glycine and gamma-aminobutyric acid receptors. 168
Localization and age-dependent expression of hexokinase mRNA in the rat brain 167
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. 166
Identification and functional significance of nicotinic cholinergic receptors in the rat pineal gland 165
Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia. 163
Microencephaly reduces the phosphorylation of the PKC substrate B-50/GAP43 in rat cortex and hippocampus. 162
Long-lasting behavioral alterations following an hypoxic/ischemic brain injury in neonatal rats 162
INTERACTION OF SOME 2-HYDROXYBENZYLPIPERIDINES WITH DOPAMINE RECEPTORS 161
CaMKII-dependent phosphorylation of NR2A and NR2B is decreased in animals characterized by hippocampal damage and impaired LTP. Eur. J. Neurosci. 11, 141-148, 1999. 160
Synthesis of a new series of 2,8-disubstituted-2,8-diazaspiro[4,5]decan-1-ones as a potential muscarinic agonists 157
Multiexponential T2-relaxation analysis in cerebrally damaged rats in the absence and presence of a gadolinium contrast agent. 156
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives. 154
New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study 152
Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. 152
Calcium/calmodulin-dependent protein kinase II is associated to NR2A/B subunits of NMDA receptor in post synaptic densities. J. Neurochem. 71,1733-1741,1998. 150
Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats 149
Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression 146
Photoaffinity labeling of calmodulin byphenothiazine antipsychotics. 144
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. 144
Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. 140
Cyclic nucleotide- and calcium-dependent protein phosphorylation in rat pineal gland: physiological and pharmacological regulation. 135
Activation of NK-kB and ERK 1/2 after permanent focal ischemia is abolished by simvastatin treatment. 134
In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA. 129
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. 129
EFFECTS OF POSTNATAL OR ADULT CHRONIC ACETYLCHOLINESTARASE INHIBITION ON MUSCARINIC RECEPTORS, PHOSPHOINOSITIDE TURNOVER AND M1 MRNA EXPRESSION 122
Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons. 121
1-Aminocylopropane-1-carboxylic acid derivatives as ligands at the glycine-binding site of the N-methyl-D-aspartate receptor 119
PRENATAL EXPOSURE TO ETHANOL CAUSES DIFFERENTIAL EFFECTS IN THE NERVE GROWTH FACTOR AND ITS RECEPTORS IN BASAL FOREBRAIN OF PREWEANING AND ADULT RATS 115
Studies on aging processes. 114
Identification of Cxorf1, a novel intronless gene in Xq27.3, expressed in human hippocampus. DNA and Cell Biol. 17, 1009-1016, 1998. 108
Microencephaly induces a long lasting change in B-50 phosphorylation in rats 107
Expression of neuronal acetylcholine nicotinic receptor α4 and β2 subunits during postnatal development of the rat brain 94
Increased secretion of the amino-terminal fragment of amyloid precursor protein in rat brain of animals characterized by a constitutive upregulation of protein kinase C. J. Neurochem. 68, 2523-2529, 1997 81
Interaction of thiocolchicoside with [3H]strychnine binding sites in rat spinal cord and brainstem. Eur. J. Pharmacol. 318, 201-204, 1996. 80
Totale 19.335
Categoria #
all - tutte 59.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022634 0 0 0 151 15 38 34 48 65 49 13 221
2022/20231.301 137 69 21 148 168 306 0 82 180 55 98 37
2023/2024237 36 29 17 27 21 50 11 0 1 20 8 17
2024/20251.184 53 64 330 52 21 103 123 77 114 71 68 108
2025/20265.631 249 493 1.085 520 275 165 360 64 2.018 199 140 63
2026/2027836 113 69 360 294 0 0 0 0 0 0 0 0
Totale 19.335